Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 23, 1993 - Issue 8
186
Views
58
CrossRef citations to date
0
Altmetric
Original Article

Ethacrynic acid and its glutathione conjugate as inhibitors of glutathione S-transferases

, , &
Pages 913-923 | Received 02 Apr 1993, Accepted 06 May 1993, Published online: 23 Apr 2010
 

Abstract

1. The diuretic drug ethacrynic acid (EA) is a potent reversible inhibitor of rat and human glutathione S-transferases (GST), with I50-values (πm) of 4.6–6.0, 0.3–1.9 and 3.3–4.8 π, π and π-class, respectively.

2. The reversible inhibition by the glutathione conjugate of EA is even stronger for π and π-class, with I50-values (πm) of 0.8–2.8 and <0.1–1.2, respectively, while the I50 for the π-class is 11.

3. Inhibition of rat and human π-class GST also occurs by covalent binding of ethacrynic acid. 14C-ethacrynic acid, 0.8nmol EA per nmol π-class GST could be incorporated, resulting in 65-93% inhibition of the catalytic activity.

4. Owing to the chemical nature of the covalent binding (Michael addition), this reaction should be reversible. Indeed, full restoration of the catalytic activity of GST P1-1 inactivated by covalently-bound EA was reached in about 125 h by incubation with an excess of glutathione.

5. EA has been used to inhibit GST in biological systems. The reversible covalent binding may very well play a role in the observed inhibition of GST by EA in vivo.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.